Chemours (CC) Change in Accured Expenses (2014 - 2026)

Chemours' Change in Accured Expenses history runs 13 years deep, the most recent figure standing at $12.0 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 340.0% year-over-year to $12.0 million in Q1 2026; TTM through Mar 2026 was $14.0 million, a 102.26% increase from a year earlier, with the FY2025 full-year figure at -$3.0 million, up 99.55% from the prior year.
• Change in Accured Expenses grew to $12.0 million in Q1 2026 per CC's latest filing, from -$95.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $660.0 million in Q3 2023 and bottomed at -$644.0 million in Q2 2024.
• The 5-year median for Change in Accured Expenses is -$5.0 million (2025), against an average of -$3.7 million.
• Across the five-year window, Change in Accured Expenses jumped 633.33% in 2023 and tumbled 163.89% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at -$319.0 million in 2022, then soared by 94.36% to -$18.0 million in 2023, then plunged by 100.0% to -$36.0 million in 2024, then tumbled by 163.89% to -$95.0 million in 2025, then surged by 112.63% to $12.0 million in 2026.
• Per Business Quant, the three latest CC Change in Accured Expenses figures stand at $12.0 million (Q1 2026), -$95.0 million (Q4 2025), and $22.0 million (Q3 2025).